ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $413,000 | +74.3% | 98,195 | +71.0% | 0.01% | +83.3% |
| Q4 2016 | $237,000 | +99.2% | 57,429 | +289.6% | 0.01% | +100.0% |
| Q3 2016 | $119,000 | -71.9% | 14,741 | -72.9% | 0.00% | -66.7% |
| Q2 2016 | $424,000 | +90.1% | 54,305 | +88.3% | 0.01% | +50.0% |
| Q1 2016 | $223,000 | +7.7% | 28,843 | +50.5% | 0.01% | +50.0% |
| Q4 2015 | $207,000 | +6.2% | 19,170 | -32.2% | 0.00% | +33.3% |
| Q3 2015 | $195,000 | +75.7% | 28,272 | +125.1% | 0.00% | +50.0% |
| Q2 2015 | $111,000 | -62.1% | 12,558 | -57.8% | 0.00% | -66.7% |
| Q1 2015 | $293,000 | -55.6% | 29,752 | -55.0% | 0.01% | -53.8% |
| Q3 2014 | $660,000 | +441.0% | 66,155 | +77.4% | 0.01% | +550.0% |
| Q1 2014 | $122,000 | +159.6% | 37,282 | +165.4% | 0.00% | +100.0% |
| Q4 2013 | $47,000 | 0.0% | 14,050 | -10.3% | 0.00% | 0.0% |
| Q3 2013 | $47,000 | – | 15,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |